clinical trials

Intra-Cellular reports positive Phase III trial of Caplyta in MDD and bipolar depression
Clinical Trials Arena
Wed, 03/29/23 - 09:40 am
Intra-Cellular Therapies
clinical trials
Caplyta
major depressive disorder
bipolar disorder
Viking sets ships toward phase 2 after obesity med passes early test
Fierce Biotech
Tue, 03/28/23 - 10:48 pm
Viking Therapeutics
obesity
clinical trials
VK2735
Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?
Motley Fool
Tue, 03/28/23 - 10:46 pm
clinical trials
Bristol Myers Squibb
JNJ
milvexian
stroke
Biotech heads towards big catalysts
EP Vantage
Tue, 03/28/23 - 10:24 am
biotech
clinical trials
Alnylam Pharmaceuticals
Arcus Biosciences
Argenx
Arrowhead Pharmaceuticals
Axsome Therapeutics
Bavarian Nordic
FibroGen
Gilead Sciences
Incyte
Morphic Therapeutic
PTC Therapeutics
Syndax Pharmaceuticals
Travere Therapeutics
Vaxcyte
YS Biopharma reports positive data from Covid-19 vaccine trial
Clinical Trials Arena
Tue, 03/28/23 - 10:16 am
YS Biopharma
clinical trials
COVID-19
vaccines
Help wanted: Vaxxinity seeks a partner to press ahead with Alzheimer's treatment
Fierce Biotech
Tue, 03/28/23 - 10:11 am
Vaxxinity
Alzheimer's disease
clinical trials
UB-311
Proposed FDA guidelines to strengthen oversight on accelerated approval cancer drugs
Medical Marketing and Media
Mon, 03/27/23 - 09:57 pm
FDA
clinical trials
cancer
oncology
accelerated approvals
Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
BioSpace
Mon, 03/27/23 - 11:27 am
Novartis
clinical trials
Kisqali
breast cancer
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Fierce Pharma
Mon, 03/27/23 - 11:23 am
Novo Nordisk
Rybelsus
diabetes
clinical trials
Eli Lilly
AstraZeneca stays on course to challenge Alnylam with 66-week rare disease data
Fierce Biotech
Mon, 03/27/23 - 10:22 am
AstraZeneca
Ionis Pharmaceuticals
aplontersen
Alnylam
Onpattro
clinical trials
ATTRv-PN
FDA outlines plan for digital health technologies for clinical trials
RAPS.org
Sun, 03/26/23 - 11:15 pm
FDA
regulatory
clinical trials
digital health
Valneva, Pfizer delay end date of Lyme disease vaccine phase 3 trial to 2025
Seeking Alpha
Sun, 03/26/23 - 11:12 pm
Pfizer
Valneva
clinical trials
vaccines
Lyme disease
VLA15
AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus
BioSpace
Fri, 03/24/23 - 11:50 am
AbbVie
Skyrizi
ulcerative colitis
lupus
Rinvoq
clinical trials
Hard pressed for cash, Cyclerion looks for help funding rare disease drug
Endpoints
Fri, 03/24/23 - 10:04 am
Cyclerion
clinical trials
MELAS
zagociguat
Relmada, reeling from 2 late-phase flops, plots comeback for depression drug
Fierce Biotech
Fri, 03/24/23 - 10:02 am
Relmada Therapeutics
clinical trials
depression
REL-1017
Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD
Fierce Pharma
Thu, 03/23/23 - 11:44 am
Sanofi
Regeneron
Dupixent
COPD
clinical trials
Visus concludes subject enrolment in presbyopia therapy trial
Clinical Trials Arena
Thu, 03/23/23 - 11:42 am
Visus Therapeutics
clinical trials
presbyopia
Brimochol
Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
Drugs.com
Thu, 03/23/23 - 11:41 am
Astellas
zolbetuximab
clinical trials
gastric cancer
AbbVie's Skyrizi aces ulcerative colitis study en route to new IBD showdown with J&J, Takeda
Fierce Pharma
Thu, 03/23/23 - 11:39 am
AbbVie
Skyrizi
IBD
ulcerative colitis
clinical trials
Novartis pulls the plug on UK-based cardiovascular study
Endpoints
Wed, 03/22/23 - 09:11 pm
Novartis
clinical trials
Leqvio
UK
Cardiovascular

Pages